Monitoring during thyroid surgery to predict complications
Intraoperative Monitoring (Parathormone Values and Continuous Neuromonitoring) to Predict Postoperative Complications After Total Thyroidectomy
This study is testing if using special monitoring during thyroid surgery can help doctors spot problems early and keep patients safer after their operation.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Sex | All |
| Sponsor | Central Hospital, Nancy, France Academic / other |
| Locations | 1 site (Vandœuvre-lès-Nancy) |
| Trial ID | NCT03309384 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of intraoperative continuous and intermittent neuromonitoring along with intraoperative parathormone (PTH) measurements to predict postoperative complications such as nerve injury and hypocalcemia in patients undergoing total thyroidectomy. Data will be collected prospectively from patients at the University Hospital in Nancy, focusing on postoperative outcomes within one week and one year after surgery. The aim is to improve patient safety and outcomes by identifying potential complications early.
Who should consider this trial
Good fit: Ideal candidates are patients scheduled for total thyroidectomy at the University Hospital in Nancy.
Not a fit: Patients who refuse to participate in the study will not receive any benefit from this monitoring approach.
Why it matters
Potential benefit: If successful, this approach could lead to better prediction and management of postoperative complications for thyroid surgery patients.
How similar studies have performed: While similar monitoring techniques have been explored, this specific approach is novel in its combination of continuous neuromonitoring and PTH measurement during thyroid surgery.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients scheduled for total thyroidectomy in university of Nancy (University Hospital) Exclusion Criteria: * refusal to participate
Where this trial is running
Vandœuvre-lès-Nancy
- CHU Nancy — Vandœuvre-lès-Nancy, France (Recruiting)
Study contacts
- Principal investigator: Brunaud — Central Hospital, Nancy, France
- Study coordinator: Brunaud
- Email: l.brunaud@chru-nancy.fr
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.